New World Angels

New World Angels

A Boca Raton-based angel group that invests in entrepreneurial companies within the state of Florida

New World Angels is an angel group in Boca Raton that prefers to invest in financial services, e-commerce, marketplaces, and healthcare start-ups. Founded 2003 in Boca Raton, Florida, United States, the firm invests in early stage ventures and private equity. The notable investment portfolio of New World Angels includes Aegle Therapeutics, VuPulse, Oralucent, Streann Media, Switchboard Live, Source Molecular, Cre8tor. App, Rewired Solutions, and Kairos AR. New World Angels typically invests between $0.5 million and $2.5 million. As of January 2020, New World Angels has made 28 investments and three exits.Their most recent investment was on Jan 9, 2020, when Aegle Therapeutics raised $4M.

Timeline

2003

Founded

Funded Companies

Company
Description
Industry
Website
Location
Aegle Therapeutics

Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).

Biotechnology
Miami
RecordGram

RecordGram is a Miami-based company.

Music
Miami
VirtualWorks Group

VirtualWorks Group is a software company.

Software
Source Molecular

Source Molecular is a Miami-based company.

Tracking
Miami
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Eric Picchetti

Investor

Jonathan Grabis

Employee

Orin Levy

Board member

Raj Kulkarni

Investor

Rhys L. Williams

Employee

Thomas Cardy

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Aegle Therapeutics

Cre8tor.App

Kairos AR

Oralucent

Rewired Solutions

Source Molecular

Streann Media

Switchboard Live

VuPulse

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.